Nutrición Hospitalaria 00519 / http://dx.doi.org/10.20960/nh.519

Trabajo Original

Oral glutamine reduces myocardial damage after coronary revascularization under cardiopulmonary bypass. a randomized clinical trial

Mariana Chávez Tostado, Fernando Carrillo-llamas, Porfirio Eduardo Martínez-gutiérrez, Araceli Alvarado-ramírez, Jaime Gilberto López-taylor, José Clemente Vásquez-jiménez, Clotilde Fuentes-orozco, Jorge Rendón-félix, Leire Irusteta-jiménez, Vanessa Carolina Calil-romero, José Antonio Ramírez-jiménez, Luis Rodrigo Michel-espinoza, Carmen Karina Contreras-lópez, Lizbeth Araceli Cuesta-márquez, Alejandro González-ojeda

VOLUMEN 34, NÚM. 2, marzo-abril (2017), PAG. 277-283

Logo Descargas Número de descargas: 4257 Logo Visitas Número de visitas: 8041 Citas Citas: 10

Compártelo:

Background: Glutamine is the most abundant free amino acid in the body. It modulates immune cell function and is an important energy substrate for cells in critically ill patients. Reduction of injury cardiac markers had been observed in patients receiving intravenous glutamine and in a pilot study with oral glutamine. The aim of this study was to analyze the effect of preoperative oral supplementation of glutamine on postoperative serum levels of cardiac injury markers.Methods: A randomized clinical trial was performed in 28 Mexican patients with ischemic heart disease who underwent cardiopulmonary bypass with extracorporeal circulation. Patients were randomly assigned to receive oral glutamine (0.5 g/kg/day) or maltodextrin 3 days before surgery. Cardiac injury markers as troponin-I, creatine phosphokinase, and creatine phosphokinase-Mb were measured at 1, 12, and 24 hours postoperatively.Results: At 12 and 24 hours serum markers levels were significantly lower in the glutamine group compared with controls (p = 0.01 and p = 0.001, respectively) (p = 0.004 and p < 0.001, respectively). Overall, complications were significantly lower in the glutamine group (p = 0.01, RR = 0.54, 95% CI 0.31-0.93). Mortality was observed with 2 cases of multiple organ failure in control group and 1 case of pulmonary embolism in glutamine group (p = 0.50).Conclusion: Preoperative oral glutamine standardized at a dose of 0.5 g/kg/day in our study group showed a significant reduction in postoperative myocardial damage. Lower cardiac injury markers levels, morbidity and mortality were observed in patients receiving glutamine.

Palabras Clave: Glutamine. Cardiac surgery. Cardiopulmonary bypass. Troponin-I. CPK. CPK-Mb.

Descargar PDF (ENGLISH)

Citas
Bibliografía

Norouzi, Mona, Nadjarzadeh, Azadeh, Maleki, Majid, Khayyatzadeh, Sayyed Saeid, Hosseini, Saeid, Yaseri, Mehdi, Fattahi, Hamed (2022) The effects of preoperative supplementation with a combination of beta‐hydroxy‐beta‐methylbutyrate, arginine, and glutamine on inflammatory and hematological markers of patients with heart surgery: a randomized controlled trial. BMC Surgery

F. Mostafa, Mohamed, Ahmad Ibrahim Elmorabaa, Hany, Mahmoud Mostafa, Mohammed, Mostafa Abd El Gawad, Ramy, Ismail Seddik, Mohamed, Herdan, Ragaa, Hassanien Bakr, Mostafa, Zarief Kamel, Emad (2023) Effects of preoperative intravenous glutamine administration on cardiac and renal functions in patients undergoing mitral valve replacement surgeries: A randomized double-blind controlled trial. Egyptian Journal of Anaesthesia

Zhou, Tao, Yang, Yuqing, Chen, Qianming, Xie, Liang (2019) Glutamine Metabolism Is Essential for Stemness of Bone Marrow Mesenchymal Stem Cells and Bone Homeostasis. Stem Cells International

Ferron, Marine, Denis, Manon, Persello, Antoine, Rathagirishnan, Raahulan, Lauzier, Benjamin (2019) Protein O-GlcNAcylation in Cardiac Pathologies: Past, Present, Future. Frontiers in Endocrinology

(2019) The Emerging Role of l-Glutamine in Cardiovascular Health and Disease. Nutrients

Yang, Liu, Xu, Longjin, Li, Juan, Wang, Huan, Sun, Jiahong, Yu, Ziqiang, Zhao, Xiaoqian, Zhao, Min, Xi, Bo (2022) The association of dietary glutamine supplementation with the development of high salt-induced hypertension in rats. Frontiers in Nutrition

Ahmad, Aya Hisham Moussa, Kamal Eldin, Farouk, Rashed, Mohamed Mohsen (2023) Efficacy of Perioperative Infusion of N(2)-L-alanyl-L-glutamine in Glycemic Control for Patients With Uncontrolled Diabetes Mellitus Presented for Urgent Coronary Artery Bypass Surgery: A Randomized Controlled Trial. Journal of Cardiothoracic and Vascular Anesthesia

Okur, Özkan, Diniz, Gülden, Arslan, Oğuz Alp, Can, Mehmet, Evciler, Hüseyin, Oral, Akgün, Hoşgör, Münevver (2022) L-glutamine Supplemented Nutrition Alleviates Damage Caused by Corrosİve Esophagitis in Rats. Journal of Dr Behcet Uz Children s Hospital

Naspitz, Laura, Konstantyner, Tulio (2020) Efeitos e segurança do uso pré-operatório de glutamina ou Whey Protein: Uma revisão sistemática. International Journal of Nutrology

Correia, Cláudia, Wang, Qing-Dong, Linhardt, Gunilla, Carlsson, Leif G., Ulfenborg, Benjamin, Walentinsson, Anna, Rydén-Markinhutha, Katarina, Behrendt, Margareta, Wikström, Johannes, Sartipy, Peter, Jennbacken, Karin, Synnergren, Jane (2021) Unraveling the Metabolic Derangements Occurring in Non-infarcted Areas of Pig Hearts With Chronic Heart Failure. Frontiers in Cardiovascular Medicine

References

Oliveira GP, Dias CM, Pelosi P, Rocco PRM. Understanding the mechanisms of glutamine action in critically ill patients. An Acad Bras Cienc. 2010 Jun;82(2):417-30.

Kim M, Wischmeyer PE. Glutamine. World Rev Nutr Diet.2013;105:90–6.
DOI: 10.1159/000341276

Wernerman J. Glutamine supplementation. Ann Intensive Care. 2011;1:25.
DOI: 10.1186/2110-5820-1-25

Wischmeyer PE: Glutamine: role in critical illness and ongoing clinical trials. Curr Opin Gastroenterol. 2008;24:190–7.

Coëffier M, Déchelotte P. The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome. Nutr Rev. 2005;63:65–9.
DOI: 10.1111/j.1753-4887.2005.tb00123.x

Oudemans-van Straaten HM, Bosman RJ, Treskes M, van der Spoel HJ, Zandstra DF. Plasma glutamine depletion and patient outcome in acute ICU admissions. Intensive Care Med. 2001;27(1):84–90.
DOI: 10.1007/s001340000703

Jiménez-Jiménez FJ, Cervera-Montes M, Blesa-Malpicac AL. Guidelines for specialized nutritional and metabolic support in the critically ill patient. Update. Consensus

SEMICYUC-SENPE. Nutr Hosp. 2011;26 Suppl 2:76–80.

Fuentes-Orozco C, Anaya-Prado R, González-Ojeda A, Arenas-Márquez H, Cabrera-Pivaral C, Cervantes-Guevara G et al. L-alanyl-L-glutamine-supplemented parenteral nutrition improves infectious morbidity in secondary peritonitis. Clin Nutr. 2004;23:13–21.
DOI: 10.1016/S0261-5614(03)00055-4

Wischmeyer PE, Jayakar D, Williams U, Singleton KD, Riehm J, Bacha EAet al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr.

2003;27(6):396–403.

Groening P, Huang Z, La Gamma EF, Levy RJ. Glutamine restores myocardial cytochrome c oxidase activity and improves cardiac function during experimental sepsis. JPEN J Parenter Enteral Nutr. 2011;35(2):249–54.
DOI: 10.1177/0148607110383040

Villar J, Edelson JD, Post M, Mullen JB, Slutsky AS. Induction of heat stress proteins is associated with decreased mortality in an animal model of acute lung injury. Am Rev Respir Dis. 1993;147(1):177–81.
DOI: 10.1164/ajrccm/147.1.177

Singleton KD, Beckey VE, Wischmeyer PE. Glutamine prevents activation of NF- kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock. 2005;24(6):583–9.
DOI: 10.1097/01.shk.0000185795.96964.71

Lomivorotov VV, Efremov SM, Shmirev VA, Ponomarev DN, Lomivorotov VN, Karaskov AM. Glutamine is cardioprotective in patients with ischemic heart disease following cardiopulmonary bypass. Heart Surg Forum. 2011;14(6):E384–8.

Singh G, Reid K,Meyer SR, Chou MT, Nibber T, Nibber A et al. Glutamine

Enterally After Cardiac Surgery for Inflammation Attenuation and Outcome

Improvement (GLADIATOR) Study: process of regulatory approval for a natural

health product. Am J Respir Crit Care Med. 2015;191:A3135.

Khogali SE, Harper AA, Lyall JA, Rennie MJ. Effects of l-glutamine on post-ischaemic cardiacfunction: protection and rescue. J Mol Cell Cardiol 1998;30:819–27.
DOI: 10.1006/jmcc.1998.0647

McGuinness J, Neilan TG, Cummins R, Sharkasi A, Bouchier-Hayes D, Redmond JM. Intravenous glutamine enhances COX-2 activity giving cardioprotection. J Surg Res. 2009; 152:140–7.
DOI: 10.1016/j.jss.2008.03.045

Khogali SEO, Pringle SD, Weryk BV, Rennie MJ. Is glutamine beneficial in ischemic heart disease? Nutrition. 2002;18(2):123–6.
DOI: 10.1016/S0899-9007(01)00768-7

Buijs N, Brinkmann S, Oosterink JE, Luttikhold J, Schierbeek H, Wisselink W et al. Intravenous glutamine supplementation enhances renal de novo arginine synthesis in humans: a stable isotope study. Am J Clin Nutr 2014(100):1385–91

Lurati-Buse GA, Koller MT, Grapow M, Bolliger D, Seeberger M, Filipovic M. The prognostic value of troponin release after adult cardiac surgery—a metaanalysis. Eur J Cardiothorac Surg. 2010; 37:399–406.

Preiser JC, Wernerman J. Glutamine, a lifesaving nutrient, but why? Crit Care Med. 2003;31:2555–6.

Engel JM, Mühling J, Kwapisz M, Heidt M. Glutamine administration in patients undergoing cardiac surgery and the influence on blood glutathione levels. Acta Anaesthesiol Scand. 2009;53(10):1317–23.
DOI: 10.1111/j.1399-6576.2009.02084.x

Sufit A, Weitzel LB, Hamiel C, Queensland K, Dauber I, Rooyackers O et al.

Pharmacologically dosed oral glutamine reduces myocardial injury in patients

undergoing cardiac surgery: a randomized pilot feasibility trial. JPEN J

Parenter Enteral Nutr. 2012;36(5):556–61.

Mansour A, Mohajeri-Tehrani MR, Qorbani M, Heshmat R, Larijani B, Hosseini S. Effect of glutamine supplementation on cardiovascular risk factors in patients with type 2 diabetes. Nutrition. 2015;31(1):119–26.
DOI: 10.1016/j.nut.2014.05.014

Wang Y, Jiang ZM, Nolan MT, Jiang H, Han HR, Yu K et al. The impact of glutamine

Dipeptide-supplemented parenteral nutrition on outcomes of surgical patients: a

meta-analysis of randomized clinical trials. JPEN J Parenter Enteral Nutr.

2010;(34): 521– 529.

Grau T, Bonet A, Miñambres E, Piñeiro L, Irles JA, Robles A, et al. The effect of L- alanyl-L-glutamine dipeptide supplemented total parenteral nutrition on infectious

morbidity and insulin sensitivity in critically ill patients. Crit Care Med.

2011;39(6):1263–8.

Ziegler TR, Ogden LG, Singleton KD, Luo M, Fernandez-Estivariz C, Griffith DP et al. Parenteral glutamine increases serum heat shock protein 70 in critically ill patients.

Intensive Care Med. 2005;31:1079–86.